Bella Amigud
Positive Changes for R&E Tax Deductions Under OBBB
For decades, companies have navigated the complexities involved in deducting research and experimental expenditures. The One Big Beautiful Bill (OBBB) Act with the newly released Revenue Procedure 2025-28 changes that landscape. Starting with tax years after December 31, 2024, domestic research and development expenses may be deducted immediately, replacing the prior five-year capitalization and amortization […]
Life Sciences Gain R&D Tax Relief Under OBBB
Life sciences companies face some of the highest costs and longest timelines for research and development. The One Big Beautiful Bill (OBBB) Act, with the newly released IRS Revenue Procedure 2025-28, eases some of the tax complexity around these expenditures. Starting with tax years after December 31, 2024, domestic research and development expenses may be […]
What Life Science Firms Need to Know Before Expanding to the U.S.
Understanding the U.S. Market Entry Process for Life Science Companies For foreign life sciences companies, the decision to establish a presence in the United States often begins with a strategic imperative—a clinical trial site near an academic research center, access to venture funding, or proximity to biopharma partners. But once the strategic rationale is clear, […]
Megabill Provisions Raise Tax Exposure for Multinationals
The One Big Beautiful Bill Act (OBBBA), enacted in July 2025, introduces broad changes to international tax rules. These adjustments will affect U.S. corporations with foreign subsidiaries, especially those that benefit from favorable tax treatment on foreign income. While some provisions align with expectations tied to the scheduled end of the Tax Cuts and Jobs […]
Tax Strategies Shaping Life Science Innovation
Life science companies, particularly those in the start-up or growth phase, are challenged with balancing their core mission, e.g., advancing scientific discovery, with the complex financial and tax issues that arise in the process. While pursuing breakthroughs in areas like cancer treatments or novel drugs, companies need to also ensure they retain enough capital to […]
R&D Expenditures for Early Stage and Life Science Start-ups
Could your startup benefit from research and development (R&D) tax credits? Have you explored whether or not you qualify? Are you prepared to navigate tax strategies that could ease financial pressures on innovation? For early-stage and life science startups, R&D drives progress and lays the foundation for growth. However, recent changes to tax law—specifically Section […]
Top Takeaways From Our 2024 Business Tax Planning Webinar
In this article: Tax planning is an essential part of business strategy, especially as we approach year-end. During AAFCPAs’ recent Business Tax Planning webinar (October 2024), speakers discussed topics that affect U.S. privately held businesses across federal, state, and international tax landscapes. This session highlighted credits, deductions, compliance challenges, and strategies that could benefit businesses […]
Essential Tax Moves Before Year-End: Watch Our Business Tax Webinar
Webinar: Year-End Tax Planning & Compliance for Privately Held Companies AAFCPAs invites you to watch our 2024 Business Tax Planning webinar, designed to provide essential year-end tax strategies to help you maximize your 2024 tax benefits. This session covers key regulatory changes and guidance for optimizing your tax position. Details: Focused on optimizing your business […]
Year-End Tax Webinars: Optimize Your 2024 Tax Strategy
Watch OnDemand: 2024 Year-End Tax Webinars Reviewing your tax strategies before the end of the calendar year is essential to uncover potential tax savings, ensure compliance, and optimize your financial decisions, which is why AAFCPAs annually hosts a series of complimentary webinars to help clients stay informed and prepared. Whether you are a business owner, […]